Comments
Abbott India Ltd has appointed Ambati Venu as Managing Director, the multinational said after its board meeting today.
The announcement comes almost five months after its previous MD Rehan Khan resigned from the multinational in April.
The new appointment is for a five-year term and Venu will report to Bhasker Iyer, Vice President with Abbott’s Established Pharmaceuticals Division. Venu’s move to Abbott follows a 24 year long corporate career with GlaxoSmithKline Consumer Healthcare.
With experience that spans Asia, Middle East, North Africa and the Indian sub-continent, Venu’s asset is his ability to excel within diverse socio-cultural environments and build high performance teams, Abbott said.
Drugmakers in India have been seeing major changes at the top. In fact, earlier this year fellow multinational Pfizer saw the appointment of S Sridhar as the new MD, again almost five months after Aijaz Tobaccowalla resigned from the post.
Last year also saw GlaxoSmithKline Pharmaceuticals appoint Annaswamy Vaidheesh as Managing Director in the place of Dr Hasit Joshipura, who moved out of the company.
Incidentally, Indian drugmaker Cipla too saw a change at the top with Umang Vohra being elevated as MD and Global Chief Executive, even as Samina Vaziralli, was appointed Executive Vice-Chairperson. Vohra was replacing Subhanu Saxena.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.